Merci Clot Retrieval Catheter Data Show 47% Event-Free Revascularization
This article was originally published in The Gray Sheet
Executive Summary
Concentric Medical's Merci Retriever embolic retrieval system 510(k) data show a 38% mortality rate in stroke patients versus 27% in the placebo group
You may also be interested in...
Concentric Merci Brain Clot Remover Needs Randomized Trial – Panel
Stroke patient benefit from Concentric Medical's Merci Retriever embolic retrieval device should be confirmed in a randomized clinical trial, FDA's Neurological Devices Panel recommended Feb. 23 in Gaithersburg, Md
Concentric Merci Brain Clot Remover Needs Randomized Trial – Panel
Stroke patient benefit from Concentric Medical's Merci Retriever embolic retrieval device should be confirmed in a randomized clinical trial, FDA's Neurological Devices Panel recommended Feb. 23 in Gaithersburg, Md
Concentric Medical Merci
Embolism retrieval system achieved cerebral revascularization in 51% of patients in the 81-patient, Phase I MERCI trial (41/81). The success rate, based on immediate post-procedure angiography, is a more accurate figure than the previously reported 81% rate that was based on 27 patients monitored with CT 24 hours post-procedure, according to the company (1"The Gray Sheet" Jan. 5, 2004, p. 7)...